CHARACTERIZATION OF ESCHERICHIA COLI ISOLATED FROM GYNAECOLOGICAL AND UTI PATIENTS IN DISTRICT D.I. KHAN, KHYBER PAKHTUNKHWA

Main Article Content

Nasreen Saif
Amina Abid
Tauseef ul Hassan
Rahila Bano
Aleena Idrees
Muhammad Faisal

Keywords

Ampicillin; E.coli; gynaecological; UTI

Abstract

Gynaecological and urinary tract infections, which can lead to severe outcomes, are major global health issues, particularly for women. Ensuring the maintenance of a strong vaginal microbiota in women throughout their reproductive years is extremely important. Infections caused by microbial pathogens, particularly Escherichia coli, have significant implications for the well-being of women and the welfare of newborns. The rising prevalence of E. coli and antibiotic resistance underscores the urgent worldwide need to achieve safe and efficient therapy. The objective of this study was to provide a detailed description of E. coli strains obtained from gynaecological patients and analytically examine their drug resistance profiles. This analysis included the identification of antibiotic resistance genes such as blaNDM-1, blaTEM, and OXA.Acquired gynaecological infections were detected in 55% of the female patients. In the present investigation, the E. coli strains collected had a prevalence rate of 47.5%. The age cohort ranging from 36 to 45 exhibits the highest level of pollution, reaching 80%, with those aged 16 to 25 closely trailing behind. 60%. The findings indicated that individuals with GNB infections in the region exhibited multidrug resistance (MDR). Approximately 60% of the E. coli (GNB) bacteria in the area have demonstrated resistance to amoxicillin, Nitrofurantoin, Ampicillin, Sulphamethox/trimethoprim, and Meropenem, suggesting the existence of multidrug-resistant (MDR) colonies. The present study aims to provide valuable assistance to clinical practitioners in the appropriate prescription of drugs for the treatment of gynaecological infections in pregnant women.


 


 

Abstract 204 | Pdf Downloads 38

References

1. Abd El Ghany, M., Sharaf, H., Al-Agamy, M. H., Shibl, A., Hill-Cawthorne, G. A., & Hong, P. Y. (2018). Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic `ESCHERICHIA COLI isolates from Riyadh, Saudi Arabia. PloS one, 13(8), e0201613
2. Bonnin, R. A., Poirel, L., Carattoli, A., & Nordmann, P. (2012). Characterization of an IncFII plasmid encoding NDM-1 from ESCHERICHIA COLI ST131. PLoS One, 7(4), e34752.
3. Bell, M. (2014). Antibiotic misuse: a global crisis. JAMA internal medicine, 174(12), 1920-1921.
4. Coenen, S., Francis, N., Kelly, M., Hood, K., Nuttall, J., Little, P., ... & GRACE Project Group. (2013). Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough. PloS one, 8(10), e76691.
5. Castellsague, X., Pawlita, M., Roura, E., Margall, N., Waterboer, T., Bosch, F. X., ... & Riboli, E. (2014). Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. International journal of cancer, 135(2), 440- 452.
6. Gandra, S., Barter, D. M., & Laxminarayan, R. (2014). Economic burden of antibiotic resistance: how much do we really know?. Clinical microbiology and infection, 20(10), 973-980.
7. Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F.,
8. ... & Ciobanu, L. G. (2017). Global, regional, and national disabilityadjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1260-1344.
9. Jakovljevic, M., Al Ahdab, S., Jurisevic, M., & Mouselli, S. (2018). Antibiotic resistance in Syria: a local problem turns into a global threat. Frontiers in public health, 6, 212.
10. Kassebaum, N. J., Bertozzi-Villa, A., Coggeshall, M. S., Shackelford, K. A., Steiner, C., Heuton, K. R., ... & Kazi, D. S. (2014). Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 384(9947), 980-1004.
11. Kenyon, C., Colebunders, R., & Crucitti, T. (2013). The global epidemiology of bacterial vaginosis: a systematic review. American journal of obstetrics and gynecology, 209(6), 505-523.
12. Leccese Terraf, M. C., Juarez Tomás, M. S., Rault, L., Le Loir, Y., Even, S., & Nader-Macías, M. E. F. (2017). In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic ESCHERICHIA COLI. Archives of microbiology, 199, 767-774.
13. Laxminarayan, R., & Heymann, D. L. (2012). Challenges of drug resistance in the developing world. Bmj, 344.
14. Moglad, E. H. (2020). Antibiotics profile, prevalence of extended-spectrum betalactamase (ESBL), and multidrug-resistant Enterobacteriaceae from different clinical samples in Khartoum State, Sudan. International Journal of Microbiology, 2020.
15. Murray, C. J., & Lopez, A. D. (2017). Measuring global health: motivation and evolution of the Global Burden of Disease Study. The Lancet, 390(10100), 1460-1464.
16. Mulu, W., Yimer, M., Zenebe, Y., & Abera, B. (2015). Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study. BMC women's health, 15, 1-9.
17. Naghavi, M. (2019). Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. bmj, 364.
18. Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L., Schloss, J. A., & NIH HMP Working Group. (2009). The NIH human microbiome project. Genome research, 19(12), 2317-2323.
19. Sarwar, A., Butt, M. A., Hafeez, S., & Danish, M. Z. (2020). Rapid emergence of antibacterial resistance by bacterial isolates from patients of gynaecological infections in Punjab, Pakistan. Journal of Infection and Public Health, 13(12), 1972-1980.
20. Sobel, J. D. (2000). Gynecologic infections in human immunodeficiency virusinfected women. Clinical Infectious Diseases, 31(5), 1225-1233.
21. Wijeratne, D., & Fiander, A. (2018). Gynaecological disease in the developing world: a silent pandemic. The Obstetrician & Gynaecologist, 20(4), 237-244.
22. World Health Organization. (2014). Antimicrobial resistance: global report on surveillance. World Health Organization.
23. World Health Organization. (2012). Trend in maternal mortality: 1990 to 2010: WHO, UNICEF, UNFPA and The World Bank estimates.40